NASDAQ: GANXGain Therapeutics Inc Stock Ownership - Who owns Gain Therapeutics?
Insider buying vs selling
Have Gain Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Khalid Islam | Executive Chairman | 2024-08-09 | 50,000 | $1.00 | $49.95kBuy |
| Gene MacK | CFO and Interim CEO | 2024-08-09 | 14,400 | $1.01 | $14.54kBuy |
| Eric I. Richman | Director | 2024-07-01 | 12,000 | $1.21 | $14.52kBuy |
| Eric I. Richman | Director | 2024-07-01 | 5,000 | $1.23 | $6.15kBuy |
GANX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GANX insiders and whales buy or sell their stock.
GANX Shareholders
What type of owners hold Gain Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Khalid Islam | 3.35% | 930,784 | $1.68M | Insider |
| Dme Capital Management LP | 2.04% | 566,130 | $1.02M | Institution |
| Eric I. Richman | 1.10% | 304,458 | $548.02k | Insider |
| Geode Capital Management LLC | 0.96% | 267,421 | $481.36k | Institution |
| Vanguard Group Inc | 0.64% | 177,075 | $318.74k | Institution |
| Gotham Asset Management LLC | 0.57% | 158,155 | $284.68k | Institution |
| Jones Financial Companies LLLP | 0.35% | 98,250 | $176.85k | Institution |
| Marshall Wace LLP | 0.33% | 91,738 | $165.13k | Institution |
| Morgan Stanley | 0.32% | 88,512 | $159.32k | Institution |
| Blackrock Inc | 0.31% | 86,061 | $154.91k | Institution |
GANX vs Biotech Stocks
Gain Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.